Fragmented locations
It lands on the CMO / CIO / patient experience leader first, well before it shows up in any number.
Healthcare and life sciences / Regulated health enterprises
Operloom designs and builds the connected system a pharmaceutical company runs on: the website, the CRM and customer data platform, the booking and follow up and the reporting, configured as one and handed over documented.
What earns the work is accuracy, accessibility and careful separation of patient and professional information. What loses it is a system that cannot keep up with the interest it creates.
Primary conversion: Appointment, referral, patient or professional enquiry, product access or service request
01Enterprise
Before any of this is a technology question, it is an operating question. These are the conditions a pharmaceutical company works inside, and the ones the build has to answer.
It lands on the CMO / CIO / patient experience leader first, well before it shows up in any number.
Left alone it becomes a reporting problem too: the record of what happened gets assembled afterwards, from memory.
Because regulated content and sensitive data across several audiences and jurisdictions, this one compounds rather than staying still.
Fixing it is rarely a tooling decision. It is a question of where the work is supposed to stop and who picks it up next.
None of this is unusual for a pharmaceutical company, which is exactly why it goes unaddressed for so long.
02Enterprise
Every one of these already exists in some form, usually as a tool somebody chose alone. The build is mostly about the lines between them.
Where a clinician first finds the business.
The pages a clinician reads before deciding to make contact.
Qualifying questions asked once, at the point of enquiry.
Every clinician, every engagement and who owns it.
Real availability for a engagement, with the preparation time it needs.
Estimates and invoices raised from the agreed scope.
Payment taken and reconciled against the record.
Operational and lifecycle messages that arrive and are logged.
The rules that move work between systems, with human review where it matters.
What a clinician can see and do without contacting anyone.
Campaigns tracked through to the record they produced.
The measures a pharmaceutical company is actually run on.
Who is told, when, and what they are expected to do about it.
03Enterprise
A CRM and customer data platform only earns its place when it is the record everyone trusts. For a pharmaceutical company that means holding enterprise relationship and service data model with permissions, sensitive data controls and lifecycle governance and nothing nobody maintains.
Each clinician exists once, with the history attached rather than scattered across inboxes.
Stages that describe this business rather than the platform's default pipeline.
A pipeline you can read in a minute, because the fields that nobody maintains are not on it.
Where each record came from, recorded at capture and never overwritten.
Ownership is explicit, so "I thought you had it" stops being a category of loss.
The next action carried by the system rather than by memory.
Reporting out of the working system, so the numbers and the work cannot disagree.
Role-based access, reviewed when people join and when they leave.
04Enterprise
Written as it actually happens rather than as a funnel diagram. The steps that matter are the handovers.
A clinician finds the business from patients, clinicians and professional audiences with different needs.
They check whether this is the right organisation for them. This is what accuracy, accessibility and careful separation of patient and professional information is for.
They send an patient or professional enquiry. The form asks the questions that decide whether it can be scoped, and nothing else.
The patient or professional enquiry is routed and qualified against the criteria that actually predict a good engagement.
The clinician is set up with access, expectations and a first result worth having.
The engagement is delivered. What happened is recorded against the clinician, not in a separate note.
An invoice is raised from the same record, so what was agreed and what was billed cannot drift apart.
Renewal is worked before it is due, from usage rather than from the date alone.
05Enterprise
The recommended build is regulated multi brand, multi location digital experience platform. The modules below are the ones this operating model needs, not a sitemap template.
06Enterprise
These are the workflows that carry the repeatable parts of a engagement. Every one of them has a human review point, because the useful automations are the ones people trust.
07Enterprise
The categories this operating model usually has to connect. Naming a category is not a claim of partnership, certification or reseller status.
08Enterprise
Reporting is built around the decisions the business actually makes. For a pharmaceutical company that is a short list, which is the point.
Defined once and written down, so it means the same thing next quarter.
Reviewed alongside the stage it depends on, not in isolation.
Measured from the record rather than reconstructed at month end.
Tracked as a trend, because a single period rarely means anything.
09Enterprise
Email only works when it arrives. Authentication and list hygiene come before anything creative, because a message in spam is worse than no message.
10Enterprise
Discovery for a pharmaceutical company runs from patients, clinicians and professional audiences with different needs. The channels below are the ones that follow from that, and nothing is included because it is fashionable.
The foundations: crawlability, speed, structure and the markup that describes what this business is
Service, condition, product, location and educational content under expert review
Location and practitioner profile management at scale
Answering what a clinician needs to know before they will make contact
Governed education, corporate, research and trust content
Compliant acquisition with review, targeting and measurement controls
Location feedback, patient or customer experience and service recovery
Campaign pages built from the same components, so they are fast to ship and consistent to measure
11Enterprise
Quoting, invoicing and payment are built as one path rather than three tools, because the gaps between them are where revenue goes missing.
A clinician asks for pricing with enough detail attached to answer properly.
Approval is recorded against the scope it approved.
Where a deposit is how the work is committed, it is taken at that point.
Raised from the agreed scope, not retyped from it.
Without a phone call, and reconciled automatically.
Available to the clinician rather than requested from you.
Visible on the record, so chasing is informed.
12Enterprise
Scheduling for a pharmaceutical company is where most of the avoidable loss sits. multi location, provider, resource and service scheduling with routing and capacity.
Read from the real calendar, so double booking is not possible rather than unlikely.
Preparation and turnaround built into the slot, because a appointment is not only the time with the clinician.
The questions that decide whether the slot is right, asked before it is taken.
On the interval this kind of work needs, each one carrying a reschedule link.
A clinician can move a appointment without a phone call, which is how you find out early.
A clear policy applied consistently, with the slot released for rebooking.
To the right person and the right location, using rules rather than judgement.
Handled properly wherever the work crosses them.
13Enterprise
Not every business needs every capability, and pretending otherwise is how implementations get expensive. This is the mix a pharmaceutical company typically needs, split by how load bearing each part is.
CRM setup and data model supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Pipeline and lifecycle design supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Lead routing, scoring and follow up supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Website build or redesign supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Service and landing pages supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Email infrastructure and deliverability supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Email campaigns, nurture and reminders supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Analytics and conversion tracking supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Dashboards and attribution supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Client, patient or customer portal supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Help desk and service workflows supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Platform integrations and APIs supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Security, privacy and maintenance supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Multi location and franchise management supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Enterprise governance and data architecture supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Technical and on page SEO supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Content strategy and copywriting supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Documents, forms and e signature supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
Workflow automation supports pharmaceutical company businesses by helping to improve access and service experience while maintaining enterprise governance and compliance
14Enterprise
Better systems do not guarantee a commercial result, and nobody should promise one. What they do is remove specific failure points. These are the ones that matter for a pharmaceutical company, and the measures that would show whether the change worked.
Making the second engagement as deliberate as the first, rather than leaving it to whoever remembers.
Measure: JourneyKnowing what is committed, what is quoted and what is at risk, without rebuilding the picture by hand each month.
Measure: LocationRemoving the steps between interest and a committed engagement, and making the next action obvious at every point.
Measure: ServiceAsking the qualifying questions at the point of enquiry, so the engagement is scoped before anyone spends time on it.
Measure: Appointment and conversion reporting with sensitive data protectionsCutting the gap between an patient or professional enquiry arriving and a person answering it, which is usually the single largest lever.
Measure: JourneyTaking the repeatable parts of the engagement out of somebody's head and putting them into a workflow that runs whether or not it is a busy week.
Measure: Location15Enterprise
Mapping the real process, which is rarely the documented one, and pricing what the gaps cost.
How an patient or professional enquiry should become a engagement, agreed and written down before anything is configured.
Build and configure, sequenced so the part that is losing work today is fixed first.
The handovers between Clinical or industry systems, CRM, identity, payments, documents, analytics and data platforms made explicit and monitored.
Workflow maps, field definitions, ownership and runbooks, written for the people who will use them.
Measurement built in rather than added afterwards, when the baseline has already gone.
Regular review with a small change list, judged against the baseline rather than against opinion.
16Enterprise
Concrete deliverables, not projected commercial results. What each one achieves depends on how it is used after handover.
17Enterprise
Recommended starting scope
Regulated Enterprise Experience and Operations
A starting scope rather than a fixed package. The plan page sets out who it is for, the core deliverables, the modules, the integrations and the measures.
Core measures
Scope varies with what already exists, so we do not publish a figure. Tell us what you have and you will get a scoped proposal with the assumptions written down.
18Enterprise
Sensitive data, consent, regulatory advertising, accessibility, records and audit requirements.
That is a factual summary of the areas that tend to apply, not advice. Requirements vary by jurisdiction and change. We build to what your advisers confirm applies, and we implement it properly: consent capture, retention, access control, audit trails and secure handling.
19Enterprise
Carefully, and within our lane. Sensitive data, consent, regulatory advertising, accessibility, records and audit requirements. We build to what your advisers tell us applies: consent capture, retention rules, access control, audit trails and secure handling. We implement requirements. We do not interpret them for you, and we will say so rather than guess.
You get the documentation, the workflow map and the training, because the point is that you own it. Ongoing support is a separate arrangement rather than an assumption: some businesses take a maintenance and improvement retainer, others take the handover and run it themselves. Both are fine, and we will tell you which one we think fits.
The scope starts from how this kind of business runs rather than from a package. In practice that means regulated multi brand, multi location digital experience platform, a CRM and customer data platform holding enterprise relationship and service data model with permissions, sensitive data controls and lifecycle governance, and the booking and follow up around it. The nearest starting point in our catalogue is Regulated Enterprise Experience and Operations, which is a scope to argue with rather than a fixed list.
It depends on how much already exists and how clean it is. A build is sequenced so that something useful goes live early rather than everything landing at once: the CRM and customer data platform and patient or professional enquiry capture first, because that is where work is lost today, then the site, then the automation, then reporting. We give a timeline after a scoping conversation, not before one.
Through a shared data model and explicit ownership rather than a single template imposed on everyone. Common definitions, governed components and one measurement layer, with local teams able to move inside agreed boundaries. Accessibility, security and documentation are part of the build rather than a later phase.
Often, yes, and it usually makes the project smaller. A maintainable site is better connected than replaced: patient or professional enquiry capture that carries its source, tracking that survives, and a clean handover into the CRM and customer data platform. The CRM question is whether it can hold enterprise relationship and service data model with permissions, sensitive data controls and lifecycle governance without being fought. If it can, we configure it properly. If it cannot, we say so and explain what migrating would actually cost you in time and disruption.
Less than most people expect, but not nothing. Access to the platforms, a decision maker who can settle scope questions in the same week they are asked, and someone who knows how the work really runs, which is rarely the same as how it is written down. Content and assets where you have them. We write what you do not.
Availability comes from the real calendar, not a copy of it, so a engagement cannot be booked into a slot that is already gone. Multi location, provider, resource and service scheduling with routing and capacity. Every booking writes back to the clinician record, so the diary and the pipeline are the same story.
Tell us what a engagement looks like now, end to end. That conversation usually makes the scope obvious, and sometimes makes it smaller.